Login / Signup

Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency.

Yuta ImaiSatomi NagayaYuhei AraisoMakiko Meguro-HorikeTomoki TogashiKensho OhmoriYuka MakitaEiichi SatoToshiaki YujiriYuta NagamoriShin-Ichi HorikeAtsushi WatanabeEriko Morishita
Published in: International journal of hematology (2022)
Hereditary antithrombin (AT) deficiency is an autosomal dominant inherited thrombophilia. In three pedigrees of hereditary type I AT deficiency, we identified novel variants c.126delC (p.Lys43Serfs * 7), c.165C > G (p.Tyr55 * ), and c.546delA (p.Lys182Asnfs * 102) in the open reading frame encoding AT in each patient. Each of these aberrant variants leads to premature termination of AT protein synthesis. To investigate whether these abnormal variants are involved in the pathogenesis of type I AT deficiency, we analyzed the function of these variants in HEK293 cells. Results of western blot analysis and immunofluorescence microscopy showed that all abnormal variants were expressed intracellularly, but p.Lys43Serfs * 7 and p.Tyr55 * protein were aggregated in the cells. These three variants were not detected in the spent culture medium, indicating that these novel variants affect protein secretion. In summary, we suggest that these variants in the AT-encoding gene are translated in the cell, but form abnormal proteins that form aggregates and/or inhibit secretion. These results provide insight into novel mechanisms of type I AT deficiency and potential therapies for the condition.
Keyphrases
  • copy number
  • induced apoptosis
  • replacement therapy
  • high resolution
  • dna methylation
  • mesenchymal stem cells
  • cell death
  • single cell
  • oxidative stress
  • climate change
  • south africa
  • optical coherence tomography